Kamada Ltd
NASDAQ:KMDA
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
4.65
6.42
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Kamada Ltd
Kamada Ltd
Total Current Assets
Kamada Ltd
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Kamada Ltd
NASDAQ:KMDA
|
Total Current Assets
$164.4m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Total Current Assets
$28m
|
CAGR 3-Years
70%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Total Current Assets
$295.1m
|
CAGR 3-Years
33%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Total Current Assets
$7.3m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Total Current Assets
₪14.6m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
55%
|
CAGR 10-Years
15%
|
|
|
Pluri Inc
NASDAQ:PLUR
|
Total Current Assets
$27m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-6%
|
|
Kamada Ltd
Glance View
Kamada Ltd. engages in the development and production of pharmaceutical products. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
See Also
What is Kamada Ltd's Total Current Assets?
Total Current Assets
164.4m
USD
Based on the financial report for Sep 30, 2024, Kamada Ltd's Total Current Assets amounts to 164.4m USD.
What is Kamada Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
5%
Over the last year, the Total Current Assets growth was 7%. The average annual Total Current Assets growth rates for Kamada Ltd have been -3% over the past three years , 5% over the past five years , and 5% over the past ten years .
You don't have any saved screeners yet
